isosorbide has been researched along with aspirin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Z; Ji, H; Lai, Y; Li, T; Tian, J; Wan, X; Wang, L; Wang, X; Xu, J; Zhang, Y | 1 |
| Born, GV; Ciabattoni, G; Fragasso, G; Hackett, D; Lipkin, DP; Maseri, A; Patrono, C; Vejar, M | 1 |
| Clancy, JM; Gilmer, JF; Lally, MN; Moriarty, LM | 1 |
| Ashby, DT; Conditt, G; Dangas, G; Hirose, M | 1 |
| Breen, CG; Clancy, JM; Gilmer, JF; Murphy, MA; Ryder, SA; Shannon, JA | 1 |
| Carolan, CG; Clancy, JM; Gilmer, JF; Jones, M; Lally, MN; Moriarty, LM | 1 |
| Carolan, CG; Clancy, JM; Gaynor, J; Gilmer, JF; Harmon, S; Holland, V; Inkielewicz, I; Jones, M; Khan, D; Lally, MN; Medina, C; Moriarty, LM; O'Byrne, P; Radomski, A; Radomski, MW; Santos-Martinez, MJ | 1 |
| Buschhaus, B; Daigeler, A; Goertz, O; Hirsch, T; Langer, S; Ring, A; Steinau, HU; Steinstraesser, L | 1 |
| Bazou, D; Cantwell, P; Gilmer, JF; Harmon, S; Inkielewicz, I; Jones, M; Ledwidge, M; Medina, C; Radomski, MW; Santos-Martinez, MJ | 1 |
| Cefali, G; Gilmer, JF; Harmon, S; Jones, M; Kerins, DM; Ledwidge, MT; O'Connell, D; Ryan, F | 1 |
| Chen, Y; Dong, W; Guo, J; Liu, CF; Qian, G; Wang, J | 1 |
2 trial(s) available for isosorbide and aspirin
| Article | Year |
|---|---|
Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina.
Topics: Adolescent; Adult; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Coronary Circulation; Drug Therapy, Combination; Electrocardiography; Humans; Isosorbide; Middle Aged; Platelet Activation; Radioimmunoassay; Thromboxane B2 | 1990 |
Prevention of contrast-induced nephropathy by adequate hydration combined with isosorbide dinitrate for patients with renal insufficiency and congestive heart failure.
Topics: Acute Kidney Injury; Aged; Aspirin; China; Contrast Media; Coronary Angiography; Double-Blind Method; Female; Fluid Therapy; Follow-Up Studies; Heart Failure; Humans; Incidence; Infusions, Intravenous; Isosorbide; Male; Prospective Studies; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2019 |
9 other study(ies) available for isosorbide and aspirin
| Article | Year |
|---|---|
Novel hybrids of optically active ring-opened 3-n-butylphthalide derivative and isosorbide as potential anti-ischemic stroke agents.
Topics: Animals; Benzofurans; Blood-Brain Barrier; Isosorbide; Platelet Aggregation Inhibitors; Rats; Stereoisomerism; Stroke | 2013 |
Isosorbide-based aspirin prodrugs. II. Hydrolysis kinetics of isosorbide diaspirinate.
Topics: Aspirin; Butyrylcholinesterase; Catalysis; Chromatography, High Pressure Liquid; Female; Humans; Hydrogen-Ion Concentration; Hydrolysis; In Vitro Techniques; Isosorbide; Kinetics; Male; Prodrugs; Time Factors | 2002 |
Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD.
Topics: Adult; Aspirin; Atorvastatin; Cardiac Catheterization; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heptanoic Acids; Humans; Isosorbide; Pyrroles; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome; Ultrasonography, Interventional | 2002 |
Single oral dose study of two isosorbide-based aspirin prodrugs in the dog.
Topics: Administration, Oral; Animals; Arachidonic Acid; Aspirin; Collagen; Dogs; Female; Isosorbide; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests | 2003 |
Discovery of a "true" aspirin prodrug.
Topics: Aspirin; Butyrylcholinesterase; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; Esters; Humans; Hydrogen-Ion Concentration; Hydrolysis; Isosorbide; Kinetics; Models, Chemical; Prodrugs; Temperature; Time Factors | 2008 |
Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups.
Topics: Aspirin; Butyrylcholinesterase; Esters; Humans; Hydrolysis; In Vitro Techniques; Isosorbide; Models, Molecular; Nitrates; Nitric Oxide Donors; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Structure-Activity Relationship | 2009 |
Influence of anti-inflammatory and vasoactive drugs on microcirculation and angiogenesis after burn in mice.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Burns; Disease Models, Animal; Endothelium; Injections, Intraperitoneal; Isosorbide; Leukocytes; Mice; Mice, Hairless; Microcirculation; Neovascularization, Pathologic; Prostaglandins; Skin; Sodium Chloride; Vasodilator Agents | 2011 |
Differential inhibition of tumour cell-induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin.
Topics: Aspirin; Blood Platelets; Cell Communication; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Stability; Flow Cytometry; Humans; Isosorbide; Microscopy, Phase-Contrast; Niacin; Physostigmine; Platelet Aggregation; Prodrugs | 2012 |
In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin?
Topics: Animals; Apolipoproteins B; Aspirin; Blood Glucose; Chemistry, Pharmaceutical; Cholesterol, LDL; Cyclooxygenase Inhibitors; Hyperglycemia; Hypolipidemic Agents; Isosorbide; Lipid Metabolism; Lipids; Macaca fascicularis; Models, Biological; Niacin; Postprandial Period; Prodrugs; Prostaglandin D2; Salicylates; Thromboxane B2; Triglycerides | 2012 |